Avience Biomedicals share price lists at 90% premium over the IPO price (opens original article in a new tab)

Avience Biomedicals shares listed at a 90% premium over the IPO price of ₹208, with strong investor demand and funds allocated for new manufacturing facilities.

• Avience Biomedicals share price opened at ₹395.20 on NSE SME, 90% above IPO price of ₹208
• IPO was subscribed 385.32 times, with non-institutional investors subscribing 597.23 times
• Funds raised will be used for a new manufacturing facility and working capital needs
• IPO priced at ₹208 per share, with retail investors needing to invest ₹2.50 lakh minimum